Scandion Oncology announces its results for the fourth quarter and year-end 2021
Scandion Oncology (Scandion) today announces its fourth quarter and year-end report for 2021. The following is taken from the report. Bo Rode Hansen, President and CEO, comments “The fourth quarter completed a busy and successful 2021 for Scandion in which we transformed the company on substantially all accounts, increasing its fundamental value. We have prepared for the future with continued focus on fundamental value creation and are poised to enter the right partnerships for Scandion when the data are ready.” Key Figures & Highlights TDKK Q4 2021 Q4